🔗 Permalink

Inventor profile of:

Florian VON DER MÜLBE

City:

Stuttgart

Country:

Germany

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by Florian VON DER MÜLBE

The entities that hold a legal rights for patent applications filed by inventor VON DER MÜLBE Florian:

CureVac AG 14 Tübingen, Germany
CureVac Real Estate GmbH 7 Tübingen, Germany
CureVac GmbH 5 Tubingen, Germany
CureVac Manufacturing GmbH 4 Tübingen, Germany
CureVac AG 1 Tubingen, Germany
CureVac SE 1 Tübingen, Germany

Recent patent applications by VON DER MÜLBE Florian

Florian VON DER MÜLBE from Stuttgart, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250099388A1

Human necessities

LYOPHILIZATION OF RNA

#2 | 2023-06-15

US20230181765A2

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#3 | 2023-05-25

US20230157958A1

Human necessities

Lyophilization of RNA

#4 | 2023-02-23

US20230053382A1

Chemistry; metallurgy

Method for producing RNA

#5 | 2022-05-26

US20220160638A1

Human necessities

Lyophilization of RNA

#6 | 2022-05-19

US20220154253A1

Chemistry; metallurgy

METHOD FOR PRODUCING RNA

#7 | 2020-12-10

US20200383922A1

Human necessities

Lyophilization of RNA

#8 | 2020-10-01

US20200308634A1

Chemistry; metallurgy

Method for producing RNA

#9 | 2019-05-09

US20190134222A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#10 | 2018-10-04

US20180282790A1

Chemistry; metallurgy

Method for producing RNA

#11 | 2018-08-30

US20180243219A1

Human necessities

Lyophilization of RNA

#12 | 2017-07-27

US20170211068A1

Chemistry; metallurgy

IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA

#13 | 2016-12-15

US20160361438A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#14 | 2016-11-10

US20160326575A1

Chemistry; metallurgy

Method for producing RNA

#15 | 2016-05-19

US20160136301A1

Human necessities

Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions

#16 | 2016-05-19

US20160136247A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#17 | 2016-05-12

US20160129105A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#18 | 2016-04-07

US20160095912A1

Human necessities

Application of mRNA for use as a therapeutic against tumour diseases

#19 | 2016-04-07

US20160095911A1

Human necessities

Application of mRNA for use as a therapeutic against tumor diseases

#20 | 2016-03-31

US20160089426A1

Human necessities

Application of mRNA for use as a therapeutic against tumour diseases

#21 | 2016-03-31

US20160089425A1

Human necessities

APPLICATION OF mRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES

#22 | 2016-03-31

US20160089424A1

Human necessities

Application of mRNA for use as a therapeutic against tumour diseases

#23 | 2016-03-24

US20160082092A1

Human necessities

Application of mRNA for use as a therapeutic against tumour diseases

#24 | 2015-04-16

US20150104476A1

Chemistry; metallurgy

Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions

#25 | 2011-03-31

US20110077287A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED MRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

#26 | 2010-12-02

US20100303851A1

Chemistry; metallurgy

IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA

#27 | 2010-09-23

US20100239608A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS

InventorID:

1129599 ⎘